1	ISI	isi	NNP	p2=CD	2	nn	_
2	analyst	analyst	NN	_	4	nn	_
3	Mark	mark	NNP	_	4	nn	_
4	Schoenebaum	schoenebaum	NNP	_	5	nsubj	5:A0
5	says	say	VBZ	pb=say.01	0	root	_
6	Pfizer	pfizer	NNP	_	14	poss	_
7	's	's	POS	p2=NNP	6	possessive	_
8	(	(	-LRB-	_	14	punct	_
9	NYSE	nyse	NNP	p2=NN	14	nn	_
10	:	:	:	_	9	punct	_
11	PFE	pfe	NNP	p2=NN	9	appos	_
12	)	)	-RRB-	_	14	punct	_
13	final	final	JJ	_	14	amod	_
14	offer	offer	NN	_	15	nsubj	15:A1=PPT
15	is	be	VBZ	pb=be.01	5	ccomp	5:A1=PPT
16	in	in	IN	_	15	prep	15:A2=PRD
17	AstraZeneca 	astrazeneca 	NNP	_	16	pobj	_
18	(	(	-LRB-	_	5	punct	_
19	NYSE	nyse	NNP	p2=NN	27	nsubj	27:A0=PAG
20	:	:	:	_	19	punct	_
21	AZN	azn	NNP	p2=VB	19	appos	_
22	)	)	-RRB-	_	21	punct	_
23	shareholders	shareholder	NNS	_	25	poss	_
24	'	'	POS	p2=''	23	possessive	_
25	hands	hand	NNS	_	19	appos	_
26	,	,	,	_	19	punct	_
27	calling	call	VBG	pb=call.01	5	ccomp	_
28	it	it	PRP	_	27	dobj	27:A1=PPT
29	"	"	``	_	36	punct	_
30	effectively	effectively	RB	_	36	advmod	_
31	a	a	DT	p2=''	36	det	_
32	'	'	``	p2=''	36	punct	_
33	hostile	hostile	JJ	_	36	amod	_
34	'	'	''	_	36	punct	_
35	tender	tender	NN	p2=JJ	36	nn	_
36	offer	offer	NN	_	27	oprd	27:A2=PRD
37	.	.	.	_	5	punct	_
38	"	"	''	_	5	punct	_

1	an	an	DT	_	2	det	_
2	increase	increase	NN	_	0	root	_
3	of	of	IN	_	2	prep	_
4	the	the	DT	_	6	det	_
5	cash	cash	NN	_	6	nn	_
6	consideration	consideration	NN	_	3	pobj	_
7	of	of	IN	_	6	prep	_
8	£8.78	£0	NN	p2=CD	7	pobj	_
9	per	per	IN	_	8	prep	_
10	share	share	NN	_	9	pobj	_
11	,	,	,	_	2	punct	_
12	or	or	CC	_	2	cc	_
13	£11.3	£0	CD	p2=IN	14	number	_
14	billion	#crd#	CD	_	2	conj	_
15	;	;	:	p2=,	14	punct	_
16	an	an	DT	_	17	det	_
17	increase	increase	NN	_	14	appos	_
18	in	in	IN	_	17	prep	_
19	the	the	DT	_	21	det	_
20	cash	cash	NN	_	21	nn	_
21	component	component	NN	_	18	pobj	_
22	as	as	IN	_	17	prep	_
23	a	a	DT	_	24	det	_
24	proportion	proportion	NN	_	22	pobj	_
25	of	of	IN	_	24	prep	_
26	the	the	DT	_	28	det	_
27	total	total	JJ	_	28	amod	_
28	consideration	consideration	NN	_	25	pobj	_
29	from	from	IN	_	24	prep	_
30	33	0	CD	_	31	num	_
31	%	%	NN	_	29	pobj	_
32	to	to	IN	p2=TO	29	prep	_
33	approximately	approximately	RB	_	34	advmod	_
34	45	0	CD	_	35	num	_
35	%	%	NN	_	32	pobj	_
36	;	;	,	p2=:	17	punct	_
37	a	a	DT	_	39	det	_
38	substantial	substantial	JJ	_	39	amod	_
39	increase	increase	NN	_	29	pobj	_
40	in	in	IN	_	39	prep	_
41	current	current	JJ	_	43	amod	_
42	indicative	indicative	JJ	_	43	amod	_
43	value	value	NN	_	40	pobj	_
44	of	of	IN	_	43	prep	_
45	approximately	approximately	RB	_	46	advmod	_
46	15	0	CD	_	47	num	_
47	%	%	NN	_	44	pobj	_
48	;	;	,	p2=:	17	punct	_
49	an	an	DT	_	51	det	_
50	aggregate	aggregate	JJ	p2=NN	51	amod	_
51	increase	increase	NN	_	39	appos	_
52	in	in	IN	_	51	prep	_
53	the	the	DT	_	57	det	_
54	total	total	JJ	_	57	amod	_
55	current	current	JJ	_	57	amod	_
56	indicative	indicative	JJ	_	57	amod	_
57	value	value	NN	_	52	pobj	_
58	of	of	IN	_	57	prep	_
59	approximately	approximately	RB	_	61	advmod	_
60	£9.1	£0	CD	p2=$	61	number	_
61	billion	#crd#	CD	_	58	pobj	_
62	or	or	CC	_	61	cc	_
63	$	$	$	_	65	quantmod	_
64	15.3	0	CD	_	65	number	_
65	billion	#crd#	CD	_	61	conj	_
66	.	.	.	_	17	punct	_

1	"	"	``	_	4	punct	_
2	Early	early	RB	p2=NNP	4	amod	_
3	Monday	monday	NNP	_	4	nn	_
4	morning	morning	NN	_	7	npadvmod	7:AM-TMP
5	,	,	,	_	7	punct	_
6	AstraZeneca	astrazeneca	NNP	_	7	nsubj	7:A0=PAG
7	rejected	reject	VBD	pb=reject.01	0	root	_
8	Pfizer	pfizer	NNP	_	11	poss	_
9	's	's	POS	_	8	possessive	_
10	fourth	#ord#	JJ	_	11	amod	_
11	offer	offer	NN	_	7	dobj	7:A1=PPT
12	of	of	IN	_	11	prep	_
13	£55	£0	NN	p2=NNS	12	pobj	_
14	per	per	IN	_	13	prep	_
15	share	share	NN	_	14	pobj	_
16	following	follow	VBG	p2=NN|pb=follow.04	17	amod	_
17	months	month	NNS	_	11	appos	16:A1=PPT
18	of	of	IN	_	17	prep	_
19	proposals	proposal	NNS	_	18	pobj	_
20	.	.	.	_	7	punct	_

1	An	an	DT	_	3	det	_
2	AstraZeneca	astrazeneca	NNP	_	3	nn	_
3	chairman	chairman	NN	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	that	that	IN	_	7	complm	_
6	he	he	PRP	_	7	nsubj	7:A0=PAG
7	spoke	speak	VBD	pb=speak.01	4	ccomp	4:A1=PPT
8	with	with	IN	_	7	prep	7:A2=GOL
9	Pfizer	pfizer	NNP	_	8	pobj	_
10	for	for	IN	_	7	prep	7:AM-TMP
11	more	more	JJR	_	13	amod	_
12	than	than	IN	_	13	quantmod	_
13	one	#crd#	CD	_	14	num	_
14	hour	hour	NN	_	10	pobj	_
15	on	on	IN	_	7	prep	7:AM-MNR
16	the	the	DT	_	17	det	_
17	phone	phone	NN	_	15	pobj	_
18	on	on	IN	_	7	prep	7:AM-TMP
19	Sunday	sunday	NNP	_	18	pobj	_
20	before	before	IN	_	22	mark	_
21	Pfizer	pfizer	NNP	_	22	nsubj	22:A1
22	ended	ended	VBD	pb=end.01	7	advcl	7:AM-TMP
23	discussions	discussion	NNS	_	22	dobj	22:AM-TMP
24	.	.	.	_	4	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubjpass	5:A0=PAG;3:A1=PPT
2	was	be	VBD	_	3	auxpass	_
3	prepared	prepare	VBN	p2=JJ|pb=prepare.02	0	root	_
4	to	to	TO	_	5	aux	_
5	offer	offer	VB	pb=offer.01	3	xcomp	3:A2=PRP
6	£53.50	£0	CD	p2=NN	5	dobj	5:A1=PPT
7	on	on	IN	p2=RP	5	prep	5:AM-TMP
8	Friday	friday	NNP	_	7	pobj	_
9	,	,	,	_	5	punct	_
10	before	before	IN	_	12	mark	_
11	AstraZeneca	astrazeneca	NNP	_	12	nsubj	12:A0=PAG
12	remarked	remark	VBD	pb=remark.01	3	advcl	3:AM-TMP;5:AM-TMP
13	that	that	IN	_	17	complm	_
14	the	the	DT	_	15	det	_
15	price	price	NN	_	17	nsubj	17:A1=PPT
16	should	should	MD	_	17	aux	17:AM-MOD
17	be	be	VB	pb=be.01	12	ccomp	12:A1=PPT
18	at	at	IN	p2=RB	19	advmod	_
19	least	least	JJS	p2=RBS	20	advmod	_
20	10	0	CD	_	21	num	_
21	percent	percent	NN	_	22	npadvmod	_
22	higher	high	JJR	p2=RBR	17	acomp	17:A2=PRD
23	to	to	TO	_	24	aux	_
24	value	value	VB	p2=NN|pb=value.01	17	advcl	_
25	the	the	DT	_	26	det	_
26	company	company	NN	_	24	dobj	24:A1
27	at	at	IN	_	24	prep	24:A2=PRD
28	around	around	RB	p2=IN	30	quantmod	_
29	£74	£0	CD	p2=DT	30	number	_
30	billion	#crd#	CD	_	27	pobj	_
31	.	.	.	_	3	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=DT	2	nn	_
2	chairman	chairman	NN	_	7	nsubj	7:A0
3	,	,	,	_	2	punct	_
4	Leif	leif	NNP	_	5	nn	_
5	Johansson	johansson	NNP	_	2	appos	_
6	,	,	,	_	2	punct	_
7	said	say	VBD	pb=say.01	0	root	_
8	that	that	IN	_	14	complm	_
9	the	the	DT	_	10	det	_
10	£55	£0	NN	p2=CD	14	nsubj	14:A1=PPT
11	per	per	IN	_	10	prep	_
12	share	share	NN	p2=FW	13	nn	_
13	valuation	valuation	NN	_	11	pobj	_
14	fell	fall	VBD	pb=fall.01	7	ccomp	7:A1=PPT
15	short	short	JJ	p2=RB	14	advmod	14:A4=GOL
16	.	.	.	_	7	punct	_

1	In	in	IN	_	38	prep	38:AM-LOC
2	an	an	DT	_	3	det	_
3	email	email	NN	_	1	pobj	_
4	,	,	,	_	8	punct	_
5	ISI	isi	NNP	_	6	nn	_
6	analyst	analyst	NN	_	7	nn	_
7	Schoenebaum	schoenebaum	NNP	_	8	nsubj	8:A0=PAG
8	clarified	clarify	VBD	pb=clarify.01	38	parataxis	_
9	,	,	,	_	8	punct	_
10	"	"	``	_	38	punct	_
11	While	while	IN	_	14	mark	_
12	PFE	pfe	NNP	p2=NN	14	nsubj	14:A0=PAG
13	certainly	certainly	RB	_	14	advmod	14:AM-ADV
14	has	have	VBZ	pb=have.03	38	advcl	38:AM-ADV
15	the	the	DT	_	17	det	_
16	financial	financial	JJ	_	17	amod	_
17	ability	ability	NN	_	14	dobj	14:A1=PPT
18	to	to	TO	_	19	aux	_
19	raise	raise	VB	pb=raise.01	17	infmod	_
20	the	the	DT	_	23	det	_
21	price	price	NN	_	22	nn	_
22	~10	~0	NN	p2=CD	23	nn	_
23	%	%	NN	_	19	dobj	19:A1=PPT
24	,	,	,	_	27	punct	_
25	this	this	DT	_	27	nsubj	27:A0=PAG
26	would	would	MD	_	27	aux	27:AM-MOD
27	mean	mean	VB	pb=mean.01	38	ccomp	_
28	-	-	HYPH	p2=,	29	hyph	_
29	based	base	VBN	_	27	prep	_
30	on	on	IN	_	29	prep	_
31	consensus	consensus	NN	_	33	nn	_
32	AZN	azn	NNP	p2=NN	33	nn	_
33	estimates	estimate	NNS	p2=VBZ	30	pobj	_
34	-	-	:	p2=HYPH	38	punct	_
35	that	that	IN	p2=DT	38	mark	_
36	PFE	pfe	NNP	p2=NN	38	nsubj	38:A0=PAG
37	is	be	VBZ	_	38	aux	_
38	creating	create	VBG	pb=create.01	0	root	8:A1-DSP
39	very	very	RB	_	40	advmod	_
40	little	little	JJ	p2=RB	45	amod	_
41	(	(	-LRB-	_	45	punct	_
42	if	if	IN	_	43	mark	_
43	any	any	DT	_	45	det	_
44	)	)	-RRB-	_	45	punct	_
45	NPV	npv	NN	p2=NNP	38	dobj	38:A1=PPT
46	for	for	IN	_	45	prep	_
47	its	its	PRP$	_	48	poss	_
48	shareholders	shareholder	NNS	_	46	pobj	_
49	.	.	.	_	38	punct	_

1	However	however	RB	_	5	advmod	5:AM-DIS
2	,	,	,	_	5	punct	_
3	PFE	pfe	NNP	_	5	nsubj	5:A0=PAG
4	may	may	MD	_	5	aux	5:AM-MOD
5	have	have	VB	pb=have.03	0	root	_
6	a	a	DT	_	9	det	_
7	very	very	RB	_	8	advmod	_
8	different	different	JJ	_	9	amod	_
9	view	view	NN	_	5	dobj	5:A1=PPT
10	of	of	IN	_	9	prep	_
11	AZN	azn	NNP	_	15	poss	_
12	's	's	POS	p2=VBZ	11	possessive	_
13	out	out	JJ	p2=RP	15	amod	_
14	year	year	NN	_	15	nn	_
15	prospects	prospect	NNS	p2=VBZ	10	pobj	_
16	than	than	IN	_	15	prep	_
17	consensus	consensus	NN	_	16	pobj	_
18	does	do	VBZ	_	36	aux	_
19	-	-	:	p2=,	5	punct	_
20	if	if	IN	_	21	mark	_
21	so	so	RB	_	5	advmod	_
22	,	,	,	_	3	punct	_
23	PFE	pfe	NNP	p2=PRP	27	poss	_
24	's	's	POS	_	23	possessive	_
25	internal	internal	JJ	_	27	amod	_
26	"	"	``	p2=''	27	punct	_
27	NPV	npv	NNP	p2=NN	32	npadvmod	_
28	breakeven	breakeven	RB	p2=NNP	27	advmod	_
29	"	"	''	p2=``	32	punct	_
30	price	price	NN	_	32	nsubj	32:A1=PPT
31	might	might	MD	_	32	aux	32:AM-MOD
32	be	be	VB	pb=be.01	5	advcl	_
33	materially	materially	RB	_	34	advmod	_
34	higher	high	JJR	_	32	acomp	32:A2=PRD
35	than	than	IN	_	34	prep	_
36	~	~	VB	p2=VBG|pb=~.01	35	pcomp	_
37	$	$	$	_	38	nmod	_
38	92.5	0	CD	_	36	dobj	36:A1
39	+	+	CC	p2=CD	38	cc	_
40	10	0	CD	_	41	num	_
41	%	%	NN	_	38	conj	_
42	.	.	.	_	32	punct	_

1	However	however	RB	_	13	advmod	13:AM-DIS
2	,	,	,	_	13	punct	_
3	for	for	IN	_	6	mark	_
4	PFE	pfe	NNP	p2=NN	6	nsubj	6:A0=PAG
5	to	to	TO	_	6	aux	_
6	increase	increase	VB	pb=increase.01	13	advcl	13:AM-ADV
7	its	its	PRP$	_	8	poss	_
8	bid	bid	NN	p2=VBN	6	dobj	6:A1=PPT
9	,	,	,	_	13	punct	_
10	AZN	azn	NNP	p2=WRB	11	nn	_
11	shareholders	shareholder	NNS	p2=VBZ	13	nsubj	13:A0=PAG;15:A0=PAG;18:A0=PAG
12	probably	probably	RB	_	13	advmod	13:AM-ADV
13	need	need	VBP	pb=need.01	0	root	_
14	to	to	TO	_	15	aux	_
15	speak	speak	VB	pb=speak.01	13	xcomp	13:A1=PPT
16	up	up	RP	_	15	prt	15:C-V
17	and	and	CC	_	15	cc	_
18	force	force	VB	pb=force.01	15	conj	_
19	the	the	DT	_	20	det	_
20	board	board	NN	_	18	dobj	18:A1=PPT
21	into	into	IN	_	18	prep	18:A2=PRD
22	a	a	DT	_	23	det	_
23	negotiation	negotiation	NN	_	21	pobj	_
24	with	with	IN	_	23	prep	_
25	PFE	pfe	NNP	p2=NN	24	pobj	_
26	.	.	.	_	13	punct	_

1	"	"	``	_	16	punct	_
2	The	the	DT	_	7	det	_
3	28	0	CD	_	5	hmod	_
4	-	-	HYPH	_	5	hyph	_
5	day	day	NN	_	7	nn	_
6	negotiating	negotiating	NN	p2=VBG	7	nn	_
7	period	period	NN	_	16	nsubj	8:A1=PPT;16:A1=PPT
8	governed	govern	VBN	pb=govern.01	7	partmod	_
9	by	by	IN	_	8	agent	8:A0=PAG
10	the	the	DT	_	12	det	_
11	United	united	NNP	_	12	nn	_
12	Kingdom	kingdom	NNP	_	15	poss	_
13	's	's	POS	_	12	possessive	_
14	Takeover	takeover	NNP	p2=NN	15	nn	_
15	Code	code	NNP	_	9	pobj	_
16	ends	end	VBZ	pb=end.01	0	root	_
17	May	may	NNP	_	16	npadvmod	16:AM-TMP
18	26	0	CD	_	17	num	_
19	,	,	,	_	16	punct	_
20	unless	unless	IN	_	24	mark	_
21	both	both	DT	_	22	det	_
22	companies	company	NNS	_	24	nsubj	24:A0=PAG
23	mutually	mutually	RB	_	24	advmod	24:AM-MNR
24	request	request	VBP	pb=request.01	16	advcl	16:AM-ADV
25	an	an	DT	_	26	det	_
26	extension	extension	NN	_	24	dobj	24:A1=PPT
27	.	.	.	_	16	punct	_

1	Reuters	reuters	NNP	p2=NNS	2	nsubj	2:A0=PAG
2	reported	report	VBD	pb=report.01	0	root	_
3	that	that	IN	_	5	complm	_
4	AstraZeneca	astrazeneca	NNP	_	5	nsubj	5:A0
5	sees	see	VBZ	pb=see.01	2	ccomp	2:A1
6	no	no	DT	_	7	det	_
7	prospect	prospect	NN	_	5	dobj	5:A1
8	of	of	IN	_	7	prep	_
9	the	the	DT	_	11	det	_
10	Pfizer	pfizer	NNP	_	11	nn	_
11	deal	deal	NN	_	8	pobj	_
12	before	before	IN	_	11	prep	_
13	May	may	NNP	_	12	pobj	_
14	26	0	CD	_	13	num	_
15	.	.	.	_	2	punct	_

1	Shares	share	NNS	_	5	nsubj	5:A1=PPT
2	of	of	IN	_	1	prep	_
3	AstraZeneca	astrazeneca	NNP	_	2	pobj	_
4	have	have	VBP	p2=VB	5	aux	_
5	traded	trade	VBN	pb=trade.01	0	root	_
6	as	as	RB	_	7	advmod	_
7	low	low	JJ	_	5	advmod	5:A3=PPT
8	as	as	IN	_	7	prep	_
9	$	$	$	_	10	quantmod	_
10	70.35	0	CD	_	8	pobj	_
11	on	on	IN	_	5	prep	5:AM-TMP
12	Monday	monday	NNP	_	11	pobj	_
13	,	,	,	_	5	punct	_
14	down	down	IN	p2=RB	5	prep	5:AM-PRD
15	more	more	JJR	_	17	amod	_
16	than	than	IN	_	17	quantmod	_
17	14	0	CD	_	18	num	_
18	percent	percent	NN	_	14	pobj	_
19	,	,	,	_	5	punct	_
20	following	follow	VBG	_	5	prep	5:AM-TMP
21	the	the	DT	_	22	det	_
22	company	company	NN	_	24	poss	_
23	's	's	POS	_	22	possessive	_
24	rejection	rejection	NN	_	20	pobj	_
25	of	of	IN	_	24	prep	_
26	the	the	DT	_	32	det	_
27	final	final	JJ	_	32	amod	_
28	$	$	$	_	30	quantmod	_
29	119	0	CD	_	30	number	_
30	billion	#crd#	CD	_	32	nn	_
31	takeover	takeover	NN	_	32	nn	_
32	offer	offer	NN	_	25	pobj	_
33	.	.	.	_	5	punct	_

